You are here

Resource Center

CMS to Review Current Coverage Policy on Ocular Photodynamic Therapy (OPT) with Vereporfin for Macular Degeneration (CAG-00066R4)

Fact Sheet

application/pdf - 76.03 kB
Date:
07/25/2013
Issues: